Guobos vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 166,106 | 106,027 | 173,387 | 178,503 | 185,051 | 209,208 | 243,029 | 262,401 |
| Profit before tax | -3,079 | -245 | 12,591 | 9,495 | 5,900 | 5,011 | 1,892 | 9,624 |
| Net profit | -3,079 | -245 | 12,154 | 9,020 | 5,187 | 4,663 | 1,641 | 9,135 |
| Equity | -1,583 | -1,829 | 10,325 | 19,345 | 24,532 | 26,796 | 28,436 | 36,071 |
| Liabilities | 25,764 | 22,065 | 7,825 | 891 | 6,719 | 6,973 | 10,819 | 10,303 |
| Non-current assets | 536 | 210 | 116 | 393 | 6,033 | 5,817 | 4,962 | 4,365 |
| Current assets | 23,472 | 19,719 | 17,784 | 19,522 | 24,767 | 27,591 | 33,960 | 41,632 |
| Total assets | 24,008 | 19,929 | 17,900 | 19,915 | 30,800 | 33,408 | 38,922 | 45,997 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 3,343 | - | 3,067 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +8.1% | -36.2% | +63.5% | +3.0% | +3.7% | +13.1% | +16.2% | +8.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -12.8% | -1.2% | 67.9% | 45.3% | 16.8% | 14.0% | 4.2% | 19.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 117.7% | 46.6% | 21.1% | 17.4% | 5.8% | 25.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -1.9% | -0.2% | 7.0% | 5.1% | 2.8% | 2.2% | 0.7% | 3.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -1.9% | -0.2% | 7.3% | 5.3% | 3.2% | 2.4% | 0.8% | 3.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.8 | 0.0 | 0.3 | 0.3 | 0.4 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 33,221 | 35,342 | 57,796 | 59,501 | 61,684 | 69,736 | 81,010 | 101,576 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Guobos vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-16 | 2026-06-22 | 0.15 |
| 2026-05-17 | 2026-06-08 | 0.15 |
| 2026-05-03 | 2026-05-10 | 0.15 |
| 2026-04-24 | 2026-04-29 | 0.15 |
| 2021-11-16 | 2021-11-18 | 0.43 |
Guobos vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-28 | 2026-07-07 | 0.01 |
| 2026-05-28 | 2026-06-05 | 0.01 |
| 2026-04-30 | 2026-05-20 | 0.01 |
| 2026-03-29 | 2026-04-26 | 0.01 |
| 2026-02-28 | 2026-03-27 | 0.01 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Guobos vaistine, UAB (code 152837128) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €262.4K, up 8.0% year on year and 25.4% over two years. Net profit improved to €9.1K from €1.6K in 2024 and €4.7K in 2023, while the net margin rose to 3.5% after 0.7% in 2024 and 2.2% in 2023. This shows a recovery in profitability after a weaker 2024 and a stronger operating performance in the latest year. The balance sheet also expanded in 2025, with total assets of €46.0K, equity of €36.1K and liabilities of €10.3K. Equity represented 78.4% of assets, and debt-to-equity was 0.29, indicating a conservative capital structure. Return on equity was 25.3% and return on assets 19.9%, supported by an asset turnover of 5.70x. Revenue per employee was €131.2K and profit per employee €4.6K.